期刊文献+

重组新城疫病毒rl-RVG抑制A549荷瘤鼠的瘤体生长 被引量:1

Inhibition of recombinant NDV( rl-RVG)in nude mice model with lung adenocarcinoma A549
下载PDF
导出
摘要 目的探讨稳定表达狂犬病毒糖蛋白的重组新城疫病毒疫苗对人肺腺癌A549细胞荷瘤鼠的生长抑制及其可能促凋亡机制。方法将rl-RVG感染到成功建立的A549荷瘤鼠瘤体内,检测对瘤体生长抑制率;RT-PCR检测NDV HN基因及RVG基因的表达;TUNEL检测肿瘤细胞的凋亡;蛋白印迹法测caspase系列、Bax、Bcl-2表达;NDV及PBS作为对照。结果与对照组相比,rl-RVG组荷瘤鼠瘤体增长明显缓慢;RVG及NDV基因表达;rl-RVG组肿瘤细胞凋亡明显增加(P<0.05);rl-RVG组caspase-3,8和9高表达(P<0.01),Bax/Bcl-2比值明显高于对照组(P<0.01)。结论 rl-RVG成功感染至A549荷瘤鼠,其对A549荷瘤鼠瘤体生长有着明显的抑制作用,且可能与rl-RVG激活机体的Bcl-2和caspase家族诱导凋亡相关。 Objective To explore the effects of rl-RVG recombinant adenovirus on the proliferation of A549 lung adenocarcinoma tumor-bearing mice and the mechanism of apoptosis.Methods After being infected A549 lung adenocarcinoma tumor-bearing mice with rl-RVG,the tumor volume was detected,RT-PCR was used to detect the expression of NDV and RVG gene,tunnel assay used to determine the rate of cell apoptosis in tumour paraffin section and Western blot was applied to measure the expression of caspase,Bax and Bcl-2 proteins.Results After rl-RVG infection,the growth of tumor in rl-RVG group was inhibited effectively(P < 0.05) ; RT-PCR showed that RVG gene expressed in rl-RVG group and NDV gene expressed in both rl-RVG and NDV groups.Tunel showed that there were more tumor apoptosis in rl-RVG group (P < 0.05).Western blot showed that caspase-3,8,9 protein were highly expressed in both rl-RVG and NDV groups(P <0.01).The grayscale ratio of bax/Bcl-2 was higher in rl-RVG group(P <0.01).Conclusions Recombinant rl-RVG successfully,and effectively inhibited the growth of A549 lung adenocarcinoma,which may be attributed to activating Bax and caspase-depended apoptosis pathway.
出处 《基础医学与临床》 CSCD 北大核心 2014年第11期1537-1542,共6页 Basic and Clinical Medicine
基金 江苏省镇江市社会发展项目(SH2013041) 江苏大学医学临床科技发展基金(JLY20120006)
关键词 rl-RVG 肺癌 凋亡 rl-RVG lung cancer apoptosis
  • 相关文献

参考文献14

  • 1Siegel R,Naishadham D,Jemal A.Cancer statistics 2012[J].CA Cancer J Clin,2012,62:10-29.
  • 2Khuri FR,Herbst RS,Fossella FV.Emerging therapies in non-small-cell lung cancer[J].Ann Oncol,2001,12:739-744.
  • 3张琪,杨鸣琦,王根辈,赵忠华,范光丽.新城疫病毒和康莱特注射液联合抗肿瘤试验中瘤组织的病理变化及IL-6表达的研究[J].中国兽医杂志,2010,46(10):33-34. 被引量:6
  • 4王亚君,宋纯,李晓辉,张剑白.新城疫病毒抗人急性单核细胞白血病作用的实验研究[J].中国当代儿科杂志,2011,13(2):149-152. 被引量:2
  • 5Mullen JT,Tanabe KK.Viral oncolysis[J].Oncologist,2002,7:106-119.
  • 6Elankumaran S,Rockemarm D,Samal SK.Newcastle disease virus exerts oncolysis by bothintrinsic and extrinsic caspase-dependent pathways of cell death[J].J Virol,2006,80:7522-7534.
  • 7Hrabák A,Csuka I,Bajor T,et al.The cytotoxic antitumor effect of MTH-68/H,a live attenuated Newcastle disease virus is mediated by the induction of nitric oxide synthesis in rat peritoneal macrophages in vitro[J].Cancer Lett,2006,231:279-289.
  • 8DiNapoli JM,Kotelkin A,Yang L,et al.Newcastle disease virus,a host range-restricted virus,as a vaccine vector for intranasal immunization against emerging pathogens[J].Proc Natl Acad Sci U S A,2007,104:9788-9793.
  • 9DiNapoli JM,Nayak B,Yang L,et al.Newcastle disease virus-vectored vaccines ex-pressing the hemagglutinin or neuraminidase protein of H5N1 highly patho-genic avian influenza virus protect against virus challenge in monkeys[J].J Virol,2010,84:1489-1503.
  • 10Letellier C,Burny A,Meujemam C.Construction of a pigeonpox virus recombinant:expression of the Newcastle disease virus (NDV) fusion glycoprotein and protection of chickens against NDV challenge[J].Areh Viml,1993,118:43-56.

二级参考文献20

  • 1袁小远,李俊,张倩.新城疫病毒的抗肿瘤作用及其研究进展[J].中国家禽,2007,29(6):53-55. 被引量:2
  • 2李宏鸣 万学勤.溶瘤病毒治疗肿瘤的研究进展.医药世界,2006,(9):121-122.
  • 3Ito Y. Interferon induclion in miee spleen cells and mouse fibroblasts(L cells) stimulated by various strains of Newcastle disease virus[J]. J Gen Virol, 1982,62:349-352.
  • 4William A Cassel, Earl Garrett. Neweaslle disease virus as an antineoplastic agent [J]. Cancer , 1965, 7 : 863- 868.
  • 5Hu.J C, Coffin R S, Davis C J, etal. A phase I study of OncuVEXGM CSF, a second-generalion oncolytic herpes Mmplex virus expressing granuIocyte macrophage colony stimulating famor[J]. Clin Cancer Res, 2006,12 : 6737- 6747.
  • 6Schirrmacher V, Haas C, Bonifer R,Ahlert T,Gerhards R,Ertel C.Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus[J].Gene Ther, 1999, 6(1): 63-73.
  • 7Vigil A, Park MS, Martinez O,Chua MA,Xiao S,Cros JF,et al. Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus[J]. Cancer Res, 2007, 67(17): 8285-8292.
  • 8Winick NJ,Carroll WL,Hunger SP.Childhood leukemia-new advances and challenges[J].N Engl J Med, 2004, 351(6): 601-603.
  • 9Wendtner CM, Kofler DM, Mayr C, Bund D, Hallek M. The potential of gene transfer into primary B-CLL cells using recombinant virus vectors[J].Leuk Lymphoma, 2004, 45(5): 897-904.
  • 10Fabian Z, Csatary CM, Szeberenyi J, Csatary LK.p53-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell lines[J]. J Virol, 2007,81(6): 2817-2830.

共引文献5

同被引文献1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部